drugset / Trial / NCT06604832

Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture

NCT06604832

RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this split-face clinical trial is to test the efficacy of microtox in improving facial skin quality, fine wrinkles, and texture. Participants will: * be randomly assigned to Group A (which will receive 20 units of neuromodulator on the left side of the forehead and a placebo saline treatment on the right side) or Group B (which will receive 20 units of neuromodulator on the left side of the forehead and 20 units of a different neuromodulator brand on the right side as a comparator) * have one treatment session at week 0, and two live assessment visits at weeks 2 and 12 * have their pictures taken at each visit to track progress

Timeline

Start
2024-09-03
Primary completion
2025-08-29
Completion
2025-09-16

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 20 iu Intramuscular
Comparator PrabotulinumtoxinA Protein / enzyme biologic 20 iu Intramuscular

Indications

No indication recorded.